CD8A and neoplasm: T lymphocytes encompass 80% of tumor-infiltrating lymphocytes (TILs) (8), and among them, CD8+ cytotoxic lymphocytes represent the effector arm of adaptive immunity anti-tumoral cells that promote the delay in cell proliferation and growth rates.